Try our Advanced Search for more refined results
July 03, 2003
JOHN UNDERWOOD v. GENETECH, INC. et al
Case Number:
2:03-cv-03983
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
November 30, 2011
Genentech Settles FCA Suit Over Cancer Drug For $20M
A Pennsylvania federal court on Tuesday dismissed a False Claims Act suit accusing Genentech Inc. of fraudulently marketing its non-Hodgkin lymphoma drug Rituxan, after the California-based biotechnology company settled the suit for $20 million.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login